Pharmacy Podcast Network

Chris Abkarians Co-Founder at Juno discusses strategies to minimize your student loan debt. Take advantage of this program: JoinJuno.loan

Intro clip from CBS 8 San Diego 

On YouTube: Pressure mounting for President Biden to wipe out student loan debt

About Juno: 

Juno’s founders, Nikhil Agarwal and Chris Abkarians were admitted to Harvard and then the dreaded tuition bill came. That summer, instead of taking expensive loans, they got 700 students from 10 schools together and negotiated lower rates for the entire group, saving their classmates ~$15K each.

Juno came into existence from their desire to make this benefit available to all future generations of students. Today, Juno is able to get the lowest rate student loans for thousands. 

Learn more: JoinJuno.loan 

See omnystudio.com/listener for privacy information.

The endocannabinoid system is influenced by compounds found the Cannabis genus of plants and involves two compounds: cannabidiol (CBD) and tetrahydrocannabinol (THC). Federal and state regulation is changing, so the medicinal and recreatoinal use of cannabis-related prodcuts continues to increase. Although not life-threatening, some patients may experience Cannabis Hyperemesis Syndrome. Fortunately, a narrative review outlines the causes and treatment to help get out the weeds of treatment.

Reference: Perisetti A, Gajendran M, Dasari C, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Annals of Gastroenterology (2020) 33, 1-8. http://www.annalsgastro.gr/files/journals/1/earlyview/2020/ev-09-2020-01-AG_5230-0528.pdf 

CPE details for GameChangers Podcast March 2021

Learning Objective: Describe the potential mechanisms and treatment options for Cannabis Hyperemesis Syndrome.

0107-0000-21-097-H01-P

0.25 CEU/2.5 Hrs (Knowledge)

Initial Release Date: 03/02/21

Expiration Date: 03/02/24

Additional CPE information is located at https://www.ceimpact.com/podcast 

See omnystudio.com/listener for privacy information.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The endocannabinoid system is influenced by compounds found the Cannabis genus of plants and involves two compounds: cannabidiol (CBD) and tetrahydrocannabinol (THC). Federal and state regulation is changing, so the medicinal and recreatoinal use of cannabis-related prodcuts continues to increase. Although not life-threatening, some patients may experience Cannabis Hyperemesis Syndrome. Fortunately, a narrative review outlines the causes and treatment to help get out the weeds of treatment.

Reference: Perisetti A, Gajendran M, Dasari C, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Annals of Gastroenterology (2020) 33, 1-8. http://www.annalsgastro.gr/files/journals/1/earlyview/2020/ev-09-2020-01-AG_5230-0528.pdf 

CPE details for GameChangers Podcast March 2021

Learning Objective: Describe the potential mechanisms and treatment options for Cannabis Hyperemesis Syndrome.

0107-0000-21-097-H01-P

0.25 CEU/2.5 Hrs (Knowledge)

Initial Release Date: 03/02/21

Expiration Date: 03/02/24

Additional CPE information is located at https://www.ceimpact.com/podcast 

See omnystudio.com/listener for privacy information.

Becky Winslow PharmD, of PGX for Pharmacists podcast, joins Eric Geyer PharmD in this mash-up 'Pharmacy Podcast' hybrid episode where we discuss not only the Plavix case but several other cases where pharmacogenomics could help make a huge difference in our healthcare system, including in how we treat opioid addiction.

Hawaii recently fined Bristol Myers Squibb and Sanofi under consumer protection standards for their drug Plavix (clopidogrel). This could be a game changing case due to the fact that it could have been prevented with more studies using pharmacogenomics. 

Special insert from KHON2 News with Hawaii Attorney General Clare Connors held a news conference on Tuesday to discuss the million-dollar lawsuit against Bristol-Myers Squibb Co. and Sanofi.

See omnystudio.com/listener for privacy information.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Becky Winslow PharmD, of PGX for Pharmacists podcast, joins Eric Geyer PharmD in this mash-up 'Pharmacy Podcast' hybrid episode where we discuss not only the Plavix case but several other cases where pharmacogenomics could help make a huge difference in our healthcare system, including in how we treat opioid addiction.

Hawaii recently fined Bristol Myers Squibb and Sanofi under consumer protection standards for their drug Plavix (clopidogrel). This could be a game changing case due to the fact that it could have been prevented with more studies using pharmacogenomics. 

Special insert from KHON2 News with Hawaii Attorney General Clare Connors held a news conference on Tuesday to discuss the million-dollar lawsuit against Bristol-Myers Squibb Co. and Sanofi.

See omnystudio.com/listener for privacy information.

Dr. Sandra Leal is currently the Executive Vice President SinfoniaRx, A TRHC Solution and APhA President. She has published and presented her work in numerous national and international publications and venues including Peru, Saudi Arabia, and Japan. She has been recognized as the Good Government Pharmacist of the Year by the APhA for her advocacy work on pharmacist provider status. Dr. Leal received two Pinnacle Award from the APhA Foundation for her progressive practice innovations and received the ASHP Best Practice Award for her leading practice in diabetes management.

Facebook/Twitter/Instagram Handle @slealrx   

LinkedIn Profile

https://www.linkedin.com/in/slealrx

National Center for Farmworker Health: www.ncfh.org

Association of Clinicians for the Underserved: https://clinicians.org/

El Rio Health:  www.elrio.org

Tabula Rasa HealthCare: https://www.tabularasahealthcare.com/

American Pharmacists Association: www.pharmacist.com

APhA Annual Meeting Link: https://apha2021.pharmacist.com//index.asp?

See omnystudio.com/listener for privacy information.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Sandra Leal is currently the Executive Vice President SinfoniaRx, A TRHC Solution and APhA President. She has published and presented her work in numerous national and international publications and venues including Peru, Saudi Arabia, and Japan. She has been recognized as the Good Government Pharmacist of the Year by the APhA for her advocacy work on pharmacist provider status. Dr. Leal received two Pinnacle Award from the APhA Foundation for her progressive practice innovations and received the ASHP Best Practice Award for her leading practice in diabetes management.

Facebook/Twitter/Instagram Handle @slealrx   

LinkedIn Profile

https://www.linkedin.com/in/slealrx

National Center for Farmworker Health: www.ncfh.org

Association of Clinicians for the Underserved: https://clinicians.org/

El Rio Health:  www.elrio.org

Tabula Rasa HealthCare: https://www.tabularasahealthcare.com/

American Pharmacists Association: www.pharmacist.com

APhA Annual Meeting Link: https://apha2021.pharmacist.com//index.asp?

See omnystudio.com/listener for privacy information.

Our guests today are Michelle Sherman, RPh, who is a member of the Pharmacy Podcast Network & has a podcast called the "Conscious Pharmacist Podcast" & Jay Holloway PharmD, returning for a second time to the Pharmacy Podcat to discuss: 

References, from Pharmacy Today:

https://www.pharmacytoday.org/article/S1042-0991(20)30876-8/fulltext

Pharmacists Focused on LGBTQ Communities, the latest chapter of the "Transforming a Nation" podcast series. 

Pharmacists need to acquire foundational knowledge about key concepts and terminologies relevant to the LGBTQ population.

To provide care consistent with cultural competence and humility, pharmacists must also be aware of the diversity between and within different segments of the LGBTQ community, and the intersectionality of multiple identities that shape a person’s life experiences. Furthermore, it is important to note that while various identities such as gender, sexual orientation, and gender identity intersect, one is not predictive of the other. For example, a person’s gender identity does not determine their sexual orientation and the biological sex designated at birth does not define their gender identity.11Sexual orientation is a person’s emotional, romantic, sexual attraction, or non-attraction to other people and is composed of three separate dimensions: behavior, identity, and desire. Some people may engage in same-sex sexual behavior but not identify as lesbian, gay, or bisexual. Similarly, a person may be sexually, romantically, or emotionally attracted to members of the same sex and choose not to be sexually active with same-sex partners. For research purposes, the terms “men who have sex with men” (MSM) and “women who have sex with women” (WSW) are often used to describe a person’s sexual behavior regardless of their identity.

Sex refers to a set of biological attributes primarily related to physical and physiological features. The phrase “sex assigned at birth” (SAAB) or “designated sex at birth” (DSAB) is used to describe a person’s biological sex, most often, but not exclusively, based on the external appearance of genitalia at birth. Gender is a socially constructed concept used to characterize the behaviors, actions, and qualities of women and men or girls and boys. The critical flaw of an exclusive binary paradigm is that it does not account for the inherent diversity of human gender. A more expansive conceptualization of gender recognizes that each person possesses a wide range of characteristics that may or may not be consistent with the gender binary, represent a combination of male and female, or fall somewhere in between the two.

Gender identity is a person’s inner sense of their gender. For some people, their gender identity may not be congruent with the one typically expected based on their SAAB/DSAB. They may describe themselves in a variety of ways including, but not limited to, transgender, male, female, gender fluid/genderqueer, nonbinary, agender, or as another gender. Decisions to change gender expression and/or physical appearance to be more consistent with their gender identity through medical (e.g., hormone replacement therapy), nonmedical (e.g., voice therapy, choosing an affirming name, etc.), and/or surgical options (e.g. gender affirmation/confirmation surgery) is wholly determined by the individual. 

The National LGBTQIA+ Health Education Center  

https://www.lgbtqiahealtheducation.org/ 

See omnystudio.com/listener for privacy information.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Our guests today are Michelle Sherman, RPh, who is a member of the Pharmacy Podcast Network & has a podcast called the "Conscious Pharmacist Podcast" & Jay Holloway PharmD, returning for a second time to the Pharmacy Podcat to discuss: 

References, from Pharmacy Today:

https://www.pharmacytoday.org/article/S1042-0991(20)30876-8/fulltext

Pharmacists Focused on LGBTQ Communities, the latest chapter of the "Transforming a Nation" podcast series. 

Pharmacists need to acquire foundational knowledge about key concepts and terminologies relevant to the LGBTQ population.

To provide care consistent with cultural competence and humility, pharmacists must also be aware of the diversity between and within different segments of the LGBTQ community, and the intersectionality of multiple identities that shape a person’s life experiences. Furthermore, it is important to note that while various identities such as gender, sexual orientation, and gender identity intersect, one is not predictive of the other. For example, a person’s gender identity does not determine their sexual orientation and the biological sex designated at birth does not define their gender identity.11Sexual orientation is a person’s emotional, romantic, sexual attraction, or non-attraction to other people and is composed of three separate dimensions: behavior, identity, and desire. Some people may engage in same-sex sexual behavior but not identify as lesbian, gay, or bisexual. Similarly, a person may be sexually, romantically, or emotionally attracted to members of the same sex and choose not to be sexually active with same-sex partners. For research purposes, the terms “men who have sex with men” (MSM) and “women who have sex with women” (WSW) are often used to describe a person’s sexual behavior regardless of their identity.

Sex refers to a set of biological attributes primarily related to physical and physiological features. The phrase “sex assigned at birth” (SAAB) or “designated sex at birth” (DSAB) is used to describe a person’s biological sex, most often, but not exclusively, based on the external appearance of genitalia at birth. Gender is a socially constructed concept used to characterize the behaviors, actions, and qualities of women and men or girls and boys. The critical flaw of an exclusive binary paradigm is that it does not account for the inherent diversity of human gender. A more expansive conceptualization of gender recognizes that each person possesses a wide range of characteristics that may or may not be consistent with the gender binary, represent a combination of male and female, or fall somewhere in between the two.

Gender identity is a person’s inner sense of their gender. For some people, their gender identity may not be congruent with the one typically expected based on their SAAB/DSAB. They may describe themselves in a variety of ways including, but not limited to, transgender, male, female, gender fluid/genderqueer, nonbinary, agender, or as another gender. Decisions to change gender expression and/or physical appearance to be more consistent with their gender identity through medical (e.g., hormone replacement therapy), nonmedical (e.g., voice therapy, choosing an affirming name, etc.), and/or surgical options (e.g. gender affirmation/confirmation surgery) is wholly determined by the individual. 

The National LGBTQIA+ Health Education Center  

https://www.lgbtqiahealtheducation.org/ 

See omnystudio.com/listener for privacy information.

RxSafe & ApproRx have sponsored a gathering of 200+ pharmacy owners interested in learning more about a drug manufacturer interested in working directly with Pharmacy owners. Thanks to Bruce Kneeland and Todd Eury for hosting this LIVE presentation from March 2nd 2021.

Today was the 12th anniversary of the Pharmacy Podcast Network. The 1st podcast about the profession of pharmacy launched episode 1 on March 2nd 2009. Today the PPN has 30+ hosts & is dedicated to the success of our pharmacists & pharmacy techs.

Alex Oshmyansky, MD, PhD is the CEO & Founder at Mark Cuban Cost Plus Drug Company.

Dr. Alex along with strategic investor & business mogul Mark Cuban has launched Mark Cuban Cost Plus Drug Company, a pharmaceutical company that plans to make less expensive versions of selected generic drugs. The company's first drug is a generic version of albendazole, an antiparasitic drug used to treat hookworm. Treated early, two tablets will treat the infection; left untreated, cognitive defects and neurological problems can result.

Cost Plus Drug Company is dedicated to producing low-cost versions of high-cost generic drugs.

In this interview, Dr. Alex pledges to provide radical transparency in how they price their drugs. Dr. Alex has committed letting everyone know what it costs to manufacture, distribute, and market drugs to pharmacies. They will add a flat 15% margin to get wholesale prices. This will help to ensure they remain viable and profitable. There are no hidden costs, no middlemen, no rebates only available to insurance companies. Everybody gets the same low price for every drug they make.

The Pharmacy Podcast Network is the global leader in podcast content for the Business & Profession of Pharmacy. Since March 2009, the Pharmacy Podcast was the first audio blog for the pharmacy industry and has developed into a directory of over 25+ podcasts with different vertical informational themes. Collectively, over 2.5M downloads, more than 2,000+ episodes, and 30+ participating Pharmacists and Pharmacy Professionals hosting the podcasts.

Learn more about your ad choices. Visit megaphone.fm/adchoices